E
Eledon Pharmaceuticals, Inc. (ELDN)
NCM – Real Time Price. Currency in USD
3.78
+0.13 (3.56%)
At close: Jun 26, 2026, 4:00 PM EDT
3.85
+0.07 (1.85%)
After-hours: Jun 26, 2026, 7:34 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.78
+0.13 (3.56%)
At close: Jun 26, 2026, 4:00 PM EDT
3.85
+0.07 (1.85%)
After-hours: Jun 26, 2026, 7:34 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $6.2M significantly exceed its total debt $555.0K, ensuring strong financial flexibility
Total current assets $113.6M exceed Total current liabilities $13.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$22.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.44 | 6.05 | 10 | |
| Quick ratio | 8.44 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -373K | -374K | -359K | N/A | N/A |
| Operating Income | -40M | -43M | -71M | -83M | -86M |
| Net Income | -88M | -117M | -36M | -46M | -78M |
| EBITDA | -39M | -43M | -70M | -83M | -86M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -21.54 | 1.0 |
| Next quarter | N/A | 11.43 | 4.0 |
| Current year | N/A | -70 | 1.0 |
| Next year | N/A | 10.07 | 4.0 |
| Weighted average score | 2.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -273.54 | -199.99 | -60.46 | 3.3 |
| Y/Y | 999 | -500.84 | -312.49 | -40.79 | 3.3 |
| 3y average | 999 | 3.47 | 52.77 | -30.16 | 6.3 |
| 5y average | 999 | -39.14 | 15.83 | -35.76 | 5.3 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |